Antineoplastic Effects of 5-Aminosalicylates and Potential Cancer Preventive Role in Inflammatory Bowel Disease
Early studies from tertiary referral centers in the United States and Europe showed that patients with long-standing and extensive inflammatory bowel disease (IBD) have an increased risk of colon cancer. It was subsequently appreciated that the degree of risk depended on the population being stu...
Saved in:
Main Author: | Hugh J Freeman |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2004-01-01
|
Series: | Canadian Journal of Gastroenterology |
Online Access: | http://dx.doi.org/10.1155/2004/472192 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Clinical Experience with 5-Aminosalicylate Preparations in Inflammatory Bowel Disease - A Review
by: C.N. Williams
Published: (1987-01-01) -
Lupus-Like Syndrome Caused by 5-Aminosalicylic Acid in Patients with Inflammatory Bowel Disease
by: Andrew W Kirkpatrick, et al.
Published: (1999-01-01) -
Therapy of Inflammatory Bowel Disease using 5-Aminosalicylic Acid, 4-Aminosalicylic Acid and Olsalazine Retention Enemas: Review of Clinical Trials
by: M. Campieri, et al.
Published: (1989-01-01) -
Osteomyelitis and Osteonecrosis in Inflammatory Bowel Disease
by: Hugh J Freeman
Published: (1997-01-01) -
Monitoring for 5-aminosalicylate nephrotoxicity in adults with inflammatory bowel disease: prognostic model development and validation using data from the Clinical Practice Research Datalink
by: Abhishek Abhishek, et al.
Published: (2025-01-01)